Business · 1 sources covering this

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

CNBCLean R·3h ago
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
Read at CNBC →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/c7beea507dbb36a58fbb586cdcfce1eaf5703af5"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss"></iframe>

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

How 1 sources are covering this

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

More from Business

While Musk's Neuralink drills into skulls, China's BrainCo bets the future of brain tech is wearable

New housing law targets affordability — what it means for homebuyers and sellers

How Volkswagen’s Troubles Were Made in China

Kids Can’t Stop Watching ‘Moana.’ There’s a Scientific Explanation.

Reader

Trust & legal

Across the network